Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Morgan Stanley Maintains Equal-Weight on Elevance Health, Lowers Price Target to $485

Morgan Stanley analyst Ricky Goldwasser maintains Elevance Health (NYSE:ELV) with a Equal-Weight and lowers the price target from $533 to $485.

byBenzinga Newsdesk

July 25, 2022

1 minute read

Morgan Stanley analyst Ricky Goldwasser maintains Elevance Health (NYSE:ELV) with a Equal-Weight and lowers the price target from $533 to $485.

Amazon Filed Legal Challenge to India’s Antitrust Suspension of 2019 Future Deal

By Charles Gross

Today, 8:47 AM

-Reuters https://www.reuters.com/world/india/amazon-challenges-indias-antitrust-suspension-2019-future-deal-sources-2022-01-09/

AMZN

Roth Capital Maintains Buy on Whole Earth Brands, Raises Price Target to $20

By vishwanath@benzinga.com

Today, 8:47 AM

Roth Capital analyst George Kelly maintains Whole Earth Brands (NASDAQ:FREE) with a Buy and raises the price target from $18 to $20.

FREE

News

United Airlines Executive Says We Expect To Fly Less International Than We Anticipated Months Ago

By Benzinga Newsdesk

Today, 8:47 AM

-Reuters

UAL

Leidos Beats Q1 Aided By Government Technology Market; Reiterates FY22 Guidance

By Anusuya Lahiri

Today, 8:47 AM

Leidos Holdings, Inc (NYSE:LDOS) reported first-quarter FY22 revenue growth of 5% year-on-year to $3.49 billion, beating the consensus of $3.38 billion.…

LDOS

Morgan Stanley Maintains Equal-Weight on Elevance Health, Lowers Price Target to $485

Related Posts

Amazon Filed Legal Challenge to India’s Antitrust Suspension of 2019 Future Deal

Roth Capital Maintains Buy on Whole Earth Brands, Raises Price Target to $20

United Airlines Executive Says We Expect To Fly Less International Than We Anticipated Months Ago

Leidos Beats Q1 Aided By Government Technology Market; Reiterates FY22 Guidance